Search details
1.
Metronomic cyclophosphamide for bone marrow carcinomatosis in metastatic castration-resistant prostate cancer.
J Cancer Res Clin Oncol
; 150(2): 84, 2024 Feb 08.
Article
in English
| MEDLINE | ID: mdl-38329600
2.
First-line durvalumab in patients with PD-L1 positive, advanced non-small cell lung cancer (NSCLC) with a performance status of 2 (PS2). Primary analysis of the multicenter, single-arm phase II trial SAKK 19/17.
Eur J Cancer
; 200: 113600, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38330766
Results
1 -
2
de 2
1
Next >
>>